Northcape Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $638K | Buy |
26,312
+1,164
| +5% | +$28.2K | 0.19% | 88 |
|
|
2025
Q1 | $637K | Buy |
25,148
+9,519
| +61% | +$241K | 0.21% | 87 |
|
|
2024
Q4 | $415K | Sell |
15,629
-8,145
| -34% | -$216K | 0.13% | 104 |
|
|
2024
Q3 | $688K | Buy |
23,774
+419
| +2% | +$12.1K | 0.23% | 84 |
|
|
2024
Q2 | $653K | Buy |
23,355
+275
| +1% | +$7.69K | 0.24% | 82 |
|
|
2024
Q1 | $640K | Sell |
23,080
-4,198
| -15% | -$116K | 0.23% | 82 |
|
|
2023
Q4 | $785K | Sell |
27,278
-6,378
| -19% | -$184K | 0.28% | 78 |
|
|
2023
Q3 | $1.12M | Buy |
33,656
+2,151
| +7% | +$71.3K | 0.43% | 67 |
|
|
2023
Q2 | $1.16M | Sell |
31,505
-734
| -2% | -$26.9K | 0.42% | 65 |
|
|
2023
Q1 | $1.32M | Buy |
32,239
+21,903
| +212% | +$894K | 0.48% | 64 |
|
|
2022
Q4 | $530K | Sell |
10,336
-31,253
| -75% | -$1.6M | 0.3% | 61 |
|
|
2022
Q3 | $1.82M | Buy |
41,589
+9,363
| +29% | +$410K | 0.65% | 57 |
|
|
2022
Q2 | $1.69M | Sell |
32,226
-9,354
| -22% | -$491K | 0.65% | 51 |
|
|
2022
Q1 | $2.15M | Buy |
41,580
+8,880
| +27% | +$460K | 0.63% | 51 |
|
|
2021
Q4 | $1.93M | Buy |
+32,700
| New | +$1.93M | 0.65% | 52 |
|